{"transactions":[{"id":2858785,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-16T17:36:58.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":20000000,"price":0.001,"value":20000.0,"ownership":{"direct":true},"balance_after":23342500,"source":{"system":"sec-edgar","filing":"0001128732-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873221000003/primary_doc.xml","form_type":"4"}},{"id":3084252,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-07-13T18:39:14.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":1300000,"price":0.001,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."}],"balance_after":3342500,"source":{"system":"sec-edgar","filing":"0001128732-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873220000004/primary_doc.xml","form_type":"4"}},{"id":3084251,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-07-13T18:39:14.000Z","date":"2019-10-20","kind":"grant","acquired":true,"shares":1100000,"price":0.001,"value":1100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."}],"balance_after":2042500,"source":{"system":"sec-edgar","filing":"0001128732-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873220000004/primary_doc.xml","form_type":"4"}},{"id":3396634,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-10-07T13:19:31.000Z","date":"2019-09-02","kind":"grant","acquired":true,"shares":13000000,"price":0.001,"value":13000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Issuer effectuated a reverse stock split effective February 1, 2019 wherein one share of Common Stock of the Issuer was issued for each 20 shares of Common Stock issued and oustanding resulting in Reporting Person owning 5,850,000 shares of Common Stock of the Issuer as of that date."}],"balance_after":18850000,"source":{"system":"sec-edgar","filing":"0001128732-19-000032","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873219000032/primary_doc.xml","form_type":"4"}},{"id":3396633,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-10-07T13:04:24.000Z","date":"2018-08-27","kind":"grant","acquired":true,"shares":38000000,"price":0.001,"value":38000.0,"ownership":{"direct":true},"balance_after":117000000,"source":{"system":"sec-edgar","filing":"0001128732-19-000031","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873219000031/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-09-14"}},{"id":3396676,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-10-07T12:55:41.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":27000000,"price":0.001,"value":27000.0,"ownership":{"direct":true},"balance_after":79000000,"source":{"system":"sec-edgar","filing":"0001128732-19-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873219000030/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-06-28"}},{"id":3397256,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-10-04T23:10:19.000Z","date":"2017-07-20","kind":"grant","acquired":true,"shares":14000000,"price":0.001,"value":14000.0,"ownership":{"direct":true},"balance_after":52000000,"source":{"system":"sec-edgar","filing":"0001128732-19-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873219000029/primary_doc.xml","form_type":"4/A","original_submission_date":"2017-09-08"}},{"id":3397280,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-10-04T23:03:56.000Z","date":"2016-12-06","kind":"grant","acquired":true,"shares":28000000,"price":0.001,"value":28000.0,"ownership":{"direct":true},"balance_after":38000000,"source":{"system":"sec-edgar","filing":"0001128732-19-000028","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873219000028/primary_doc.xml","form_type":"4/A","original_submission_date":"2016-12-15"}},{"id":3397320,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-10-04T15:57:06.000Z","date":"2018-04-22","kind":"grant","acquired":true,"shares":12000000,"price":0.001,"value":12000.0,"ownership":{"direct":true},"balance_after":12000000,"source":{"system":"sec-edgar","filing":"0001128732-19-000027","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873219000027/primary_doc.xml","form_type":"4/A","original_submission_date":"2016-04-25"}},{"id":3815380,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-09-14T14:23:01.000Z","date":"2018-08-27","kind":"grant","acquired":true,"shares":38000000,"price":0.001,"value":38000.0,"ownership":{"direct":true},"balance_after":118467000,"source":{"system":"sec-edgar","filing":"0001128732-18-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873218000013/primary_doc.xml","form_type":"4"}},{"id":3881318,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-06-28T21:57:03.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":27000000,"price":0.001,"value":27000.0,"ownership":{"direct":true},"balance_after":80467000,"source":{"system":"sec-edgar","filing":"0001128732-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873218000008/primary_doc.xml","form_type":"4"}},{"id":4213526,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-09-08T13:55:46.000Z","date":"2017-07-20","kind":"grant","acquired":true,"shares":14000000,"price":0.001,"value":14000.0,"ownership":{"direct":true},"balance_after":53467000,"source":{"system":"sec-edgar","filing":"0001128732-17-000033","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873217000033/primary_doc.xml","form_type":"4"}},{"id":4520431,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":142619,"kind":"person","name":"MERZOUKI ABDERRAZZAK","position":1,"cik":"0001636418","reported_name":"MERZOUKI ABDERRAZZAK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-16T00:58:15.000Z","date":"2016-12-06","kind":"grant","acquired":true,"shares":26000000,"price":0.001,"value":26000.0,"ownership":{"direct":true},"balance_after":39467000,"source":{"system":"sec-edgar","filing":"0001128732-16-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000112873216000038/primary_doc.xml","form_type":"4"}}]}